PresentationGood day, and welcome to the Hansa Biopharma ConfIdeS Top Line Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Hansa Biopharma's CEO, Renee Aguiar-Lucander. Please go ahead.Renee Aguiar-LucanderChief Executive Officer Thank you. Good morning, good afternoon, and welcome to the Hansa Biopharma conference call to present the pivotal U.S. Phase III ConfIdeS trial top line results. This is a very exciting day ...

Hansa Biopharma (LSE:0RC7) FY Conference September 08, 2025 02:00 PM ET Company ParticipantsDouglas Tsao - Managing DirectorRenée Aguiar-Lucander - CEODouglas TsaoOkay, welcome everybody. I'm Douglas Tsao, Senior Analyst at H.C. Wainwright & Co. We are thrilled to have Hansa Biopharma with us, represented by the company's new CEO, Renée Aguiar-Lucander. You know, these fireside chats are only 20 minutes, so we have a lot of ground to cover. Renée, maybe as a starting point, just provide a quick overview of ...